2700 Research Forest Drive
8 articles with VGXI, Inc.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.
Under a Technology License Agreement with the Houston Methodist Research Institute, Contract Developer and Manufacturer VGXI Achieves Key Milestones with Establishment of Pilot Production Capabilities for RNA-Based Medicines.
Plasmid DNA Manufacturer VGXI, Inc. Selects BE&K Building Group as its Design-Build Partner for the Initial Phase of its New and Expanded Manufacturing Facility
Positive Data Announced In Phase IIb Clinical Trial Of Cystic Fibrosis Gene Therapy Manufactured By VGXI, Inc.